# Qilu SYNVA Pharmaceutical Co. Ltd - Inspection Records

Source: https://www.keypedia.com/companies/qilu-synva-pharmaceutical-co-ltd/fda44d3b-5f42-4cde-9760-cf4147fc0ef8

> Inspection records and compliance data for Qilu SYNVA Pharmaceutical Co. Ltd in Dezhou, None. Access full analysis and detailed observations.

---

## Details

- Name: Qilu SYNVA Pharmaceutical Co. Ltd
- FEI Number: 3006385404
- City: Dezhou
- State: None
- Country Name: China
- Address Line 1: 28 Licheng Ave, Linyi County
- Zip Code: None

## Related Documents

- [483 - Qilu SYNVA Pharmaceutical Co. Ltd - 2025-05-16](https://www.keypedia.com/records/483/qilu-synva-pharmaceutical-co-ltd/d5429ebd-a562-4752-85f4-d714c898528d) — source: FDA, date: May 16, 2025
- [FDA Inspection 1275186 - Qilu SYNVA Pharmaceutical Co. Ltd - 2025-05-16](https://www.keypedia.com/records/fda_inspections/qilu-synva-pharmaceutical-co-ltd/30ffc884-2b4e-4c89-a9dc-aed7726693e9) — source: FDA, date: May 16, 2025
- [FDA Inspection 1275186 - Qilu SYNVA Pharmaceutical Co. Ltd - 2025-05-16](https://www.keypedia.com/records/fda_inspections/qilu-synva-pharmaceutical-co-ltd/7398c1d2-13e4-4d0e-b30d-92df41dde77c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 16, 2025
- [FDA Inspection 1115250 - Qilu SYNVA Pharmaceutical Co. Ltd - 2019-12-13](https://www.keypedia.com/records/fda_inspections/qilu-synva-pharmaceutical-co-ltd/98f9dfc4-68b0-4ac7-b1d5-463d73859013) — classification: No Action Indicated (NAI), source: FDA, date: December 13, 2019
- [FDA Inspection 1098879 - Qilu SYNVA Pharmaceutical Co. Ltd - 2019-07-26](https://www.keypedia.com/records/fda_inspections/qilu-synva-pharmaceutical-co-ltd/a2d93be4-63c0-40b0-a088-b95799038fdb) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 26, 2019
- [FDA Inspection 980987 - Qilu SYNVA Pharmaceutical Co. Ltd - 2016-06-17](https://www.keypedia.com/records/fda_inspections/qilu-synva-pharmaceutical-co-ltd/a52407b2-ed98-4b6b-b089-41bafd040439) — classification: No Action Indicated (NAI), source: FDA, date: June 17, 2016

## Related Companies

- [Cambrex Charles City, Inc.](https://www.keypedia.com/companies/cambrex-charles-city-inc/b14d342b-e5ae-4df6-ad7a-39cd62dfb9c6)
- [Livzon New North River Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/livzon-new-north-river-pharmaceutical-co-ltd/49cdcdc8-9c6c-4486-b6cd-e404c21dd2d2)
- [Tianish Laboratories Private Limited](https://www.keypedia.com/companies/tianish-laboratories-private-limited/d87c0898-93b6-4200-b7b3-805ee819abb4)
- [PolyPeptide Laboratories Private Limited](https://www.keypedia.com/companies/polypeptide-laboratories-private-limited/bf5a7a5c-b537-4d71-87ce-a45650fd2b07)
- [Siegfried PharmaChemikalien Minden Gmbh](https://www.keypedia.com/companies/siegfried-pharmachemikalien-minden-gmbh/711ac70f-e753-40c0-92fd-687cb4eeecc2)
- [Aldrich Chemical](https://www.keypedia.com/companies/aldrich-chemical/952e715f-08fa-455a-a0ae-f640e6a24704)
- [Ajinomoto Co., Inc.](https://www.keypedia.com/companies/ajinomoto-co-inc/0cddfef7-b7e4-499f-81aa-0d5e77d331d4)
- [Zydus Lifesciences Limited](https://www.keypedia.com/companies/zydus-lifesciences-limited/882d7962-58d4-4de8-9d0b-86bf2cf4773e)
- [AstraZeneca Pharmaceuticals, LP](https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/24c4d7fa-217f-4286-8074-011be79e658f)
- [Roche Singapore Technical Operations Pte. Ltd.](https://www.keypedia.com/companies/roche-singapore-technical-operations-pte-ltd/e32730ce-85e1-4b01-8f9b-a8215d0593ca)

## Related Officers

- [Investigator](https://www.keypedia.com/people/marvin-d-jones/3101a8da-f5c1-4e0c-b4b1-b09be181be36)
